Marion Regnier

Has grant

Chargée de Recherche

Centre National de la Recherche Scientifique (CNRS)
Country flagFrance

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Diabetex funding

Open Date: 2026-01-01

Close Date: 2028-01-01

Grant: Close

Allocation Jeune chercheur francophone

Open Date: 2023-01-01

Close Date: 2025-01-01

Grant: Close

PhD fellowship

Open Date: 2014-01-01

Close Date: 2017-01-01

Articles (8)

Objectives O ‐GlcNAcylation plays a key regulatory role in hepatic physiology, and its disruption leads to fibrosis in liver‐specific OGT knockout mice (OGT LKO ), making this model valuable for studying advanced metabolic dysfunction‐associated steatohepatitis (MASH). Our objective is to demonstrate that shear wave elastography (SWE) is a suitable non‐invasive tool to characterize and follow this mouse model of liver injury. Methods We weekly monitored non‐invasively liver fibrosis progression in OGT LKO mice from 5 to 8 weeks of age, using SWE on both a high‐frequency preclinical ultrasound system (VevoF2), and a clinical reference system (Aixplorer) and assuming the liver as homogeneous, isotropic and purely elastic. Stiffness measurements were then confronted with ex vivo liver histological scoring and major gene transcripts associated with the development of the pathology. Results Weekly liver stiffness measurements demonstrated a progressive increase, correlating strongly with histological fibrosis scores ( R 2 > 0.78) and fibrosis‐related gene expression (Col3a1, Col6a1). The high‐resolution imaging capability of the VevoF2 allowed precise anatomical exploration while delivering SWE measurements consistent with the clinical device (Pearson r = 0.92). Conclusion Our study confirms that following liver stiffness fibrosis by SWE in a mouse model of liver injury is a valuable tool that correlates with ex vivo findings. This approach facilitates a better understanding of disease progression and therapeutic evaluation in preclinical models of MASH.

Year:

2026

Insulin and other growth factors are key regulators of liver gene expression, including in metabolic diseases. Most of the phosphoinositide 3-kinase (PI3K) activity induced by insulin is considered to be dependent on PI3Kα. We used mice lacking p110α, the catalytic subunit of PI3Kα, to investigate its role in the regulation of liver gene expression in health and in metabolic dysfunction-associated steatotic liver disease (MASLD). The absence of hepatocyte PI3Kα reduced maximal insulin-induced PI3K activity and signaling, promoted glucose intolerance in lean mice and significantly regulated liver gene expression, including insulin-sensitive genes, in ad libitum feeding. Some of the defective regulation of gene expression in response to hepatocyte-restricted insulin receptor deletion was related to PI3Kα signaling. In addition, though PI3Kα deletion in hepatocytes promoted insulin resistance, it was protective against steatotic liver disease in diet-induced obesity. In the absence of hepatocyte PI3Kα, the effect of diet-induced obesity on liver gene expression was significantly altered, with changes in rhythmic gene expression in liver. Altogether, this study highlights the specific role of p110α in the control of liver gene expression in physiology and in the metabolic rewiring that occurs during MASLD.

Year:

2025

Fasting initiates a coordinated metabolic response to preserve energy balance. As glycogen stores are depleted, the body transitions to mobilizing fatty acids from adipose tissue and generating ketone bodies in the liver to sustain the function of vital organs. A network of hormonal signals and transcriptional programs coordinate these adaptations. Among these, the hepatokine fibroblast growth factor 21 (FGF21) is strongly upregulated during fasting and has been proposed as a key mediator of the fasting response. To investigate the physiological functions of FGF21, we studied mice with hepatocyte-specific deletion of Fgf21 . Although the liver is the primary source of circulating FGF21 during fasting, its absence in hepatocytes did not alter typical fasting-induced gene expression or key metabolic pathways such as hepatic gluconeogenesis, adipose tissue lipolysis, or ketone production. Instead, we uncovered a distinct role for FGF21 in promoting protein appetite following a fast. These findings challenge the conventional view of hepatocyte-produced FGF21 as a fasting-acting hormone and reveal a more specialized function in guiding nutrient selection after energy depletion.

Year:

2025

Year:

2024

Insulin and other growth factors are key regulators of liver gene expression, including in metabolic diseases. Most of the phosphoinositide 3-kinase (PI3K) activity induced by insulin is dependent on PI3Kα. We used mice lacking p110α, the catalytic subunit of PI3Kα, to investigate its role in the regulation of liver gene expression in health and in Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD). The absence of hepatocyte PI3Kα signaling promoted glucose intolerance in lean mice and significantly regulated liver gene expression, including insulin-sensitive genes, in ad libitum feeding. Some of the defective regulation of gene expression in response to hepatocyte-restricted insulin receptor deletion was related to PI3Kα signaling. In addition, though PI3Kα deletion in hepatocytes promoted insulin resistance, it was protective against steatotic liver disease in diet-induced obesity. In the absence of hepatocyte PI3Kα, the effect of diet-induced obesity on liver gene expression was significantly altered, with changes in rhythmic gene expression in liver. Altogether, this study highlights the specific role of p110α in the control of liver gene expression in physiology and in the metabolic rewiring that occurs during MASLD.

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (10)

Patrice D. Cani

Full Professor

Université catholique de Louvain

BELGIUM
View details

Catherine Postic

Professor

Institut Cochin

FRANCE
View details

Pierre Gourdy

Professor

Université Paul Sabatier

FRANCE
View details

Lucia Parlati

Assistance Publique - Hôpitaux de Paris

FRANCE
View details

Alexandre Benani

Directeur de recherche

CNRS

FRANCE
View details

Julie Guillermet-Guibert

Chercheur

Université de Toulouse

FRANCE
View details

Walter Wahli

Nanyang Technological University National Institute of Education

SINGAPORE
View details

Jérémie Gautheron

INSERM

FRANCE
View details

Phillip Hawkins

Lister Fellow (1990-1993); BBSRC Fellow (1993-2003); Group Leader (2003-)

Babraham Institute

UNITED KINGDOM
View details

Céline Cruciani-Guglielmacci

Professor

Université Paris-Saclay

FRANCE
View details